1-3 of 3
Richard Sposto, Ph.D.
Close
Save search
Sort by
Journal Articles

Extremes of Weight Are Associated with Increased Treatment-Related Toxicity in High-Risk Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group,

Free
Etan Orgel, MD, Richard Sposto, Ph.D., Jemily Malvar, M.S., Nita L. Seibel, MD, Elena J. Ladas, MS, RD, Paul Gaynon, MD, David R. Freyer, DO, MS
Journal: Blood
Blood (2011) 118 (21): 3574.
https://doi.org/10.1182/blood.V118.21.3574.3574
Published: 2011
Journal Articles

Bortezomib Combined with VXLD Chemotherapy Is Highly Effective In Advanced B-Lineage Acute Lymphoblastic Leukemia Allowing Early Study Termination Due to Efficacy. A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Phase II Study

Free
Yoav H Messinger, MD, Paul Gaynon, MD, Richard Sposto, Ph.D., Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Jemily Malvar, M.S., Bruce C. Bostrom, MD
Journal: Blood
Blood (2011) 118 (21): 251.
https://doi.org/10.1182/blood.V118.21.251.251
Published: 2011
Journal Articles

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Free
Tanya Trippett, M.D., Pedro De Alarcon, M.D., Wendy London, Ph.D., Richard Sposto, Ph.D., Allen Chen, M.D., Sharon Gardner, M.D., Cindy Schwartz, M.D.
Journal: Blood
Blood (2004) 104 (11): 2496.
https://doi.org/10.1182/blood.V104.11.2496.2496
Published: 2004